publication venue for
- Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departure.. 148:105596-105596. 2024
- Characterization of population variability of 1,3-butadiene derived protein adducts in humans and mice.. 132:105171-105171. 2022
- Model systems and organisms for addressing inter- and intra-species variability in risk assessment.. 132:105197-105197. 2022
- Multi-dimensional in vitro bioactivity profiling for grouping of glycol ethers.. 101:91-102. 2019
- Development of an inhalation unit risk factor for isoprene.. 73:712-725. 2015
- Toxicological evaluation of isopropylparaben and isobutylparaben mixture in Sprague-Dawley rats following 28 days of dermal exposure.. 73:544-551. 2015
- Development of an inhalation unit risk factor for hexavalent chromium.. 68:201-211. 2014
- A systematic approach for identifying and presenting mechanistic evidence in human health assessments.. 67:266-277. 2013
- Misinterpretation of categorical rate ratios and inappropriate exposure-response model fitting can lead to biased estimates of risk: ethylene oxide case study.. 67:206-214. 2013
- Quantitative risk assessment of exposures to butadiene in EU occupational settings based on the University of Alabama at Birmingham epidemiological study.. 65:214-225. 2013
- An updated inhalation unit risk factor for arsenic and inorganic arsenic compounds based on a combined analysis of epidemiology studies.. 64:329-341. 2012
- Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment.. 64:466-480. 2012
- Development of a unit risk factor for nickel and inorganic nickel compounds based on an updated carcinogenic toxicity assessment.. 62:191-201. 2012
- Butadiene cancer exposure-response modeling: based on workers in the styrene-butadiene-rubber industry: total leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia.. 60:332-341. 2011
- Quantitative cancer risk assessment based on NIOSH and UCC epidemiological data for workers exposed to ethylene oxide.. 56:312-320. 2010
- Life-table calculations of excess risk for incidence versus mortality: ethylene oxide case study.. 55:82-89. 2009
- Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.. 46:63-83. 2006
- Use of probabilistic expert judgment in uncertainty analysis of carcinogenic potency.. 20:15-36. 1994
- Human exposure to endocrine-active chemicals: hazard assessment problems. 1997